The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

BELLUS Health Inc down $0.06

BELLUS Health Inc closed sharply lower Thursday, dropping $0.06 or 6.38% to $0.88. Over the last five days, shares have lost 9.28% and are down 37.14% for the last year to date. This security has underperformed the S&P TSX by 33.04% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.02
Updated October 8 3:34 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.80%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Total other revenue--------
Total revenue1110
Gross profit--------
Total cost of revenue--------
Total operating expense1111
Selling / general / administrative1111
Research & development0000
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----00
Other operating expenses, total--------
Operating income000-1
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Income before tax000-1
Income after tax000-1
Income tax, total0000
Net income000-1
Total adjustments to net income--------
Net income before extra. items000-1
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items000-1
Inc. avail. to common incl. extra. items000-1
Diluted net income000-1
Dilution adjustment--------
Diluted weighted average shares47474747
Diluted EPS excluding extraordinary itemsvalue per share-
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-